Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

lexaria bioscience

POPULAR ARTICLES

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway

biotech investing

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway.

biotech investing

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway.

Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program

biotech investing

Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program

LATEST ARTICLES

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7

biotech investing

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7

Lexaria Bioscience Releases Second Episode of Investor Video Series

biotech investing

Lexaria Bioscience Releases Second Episode of Investor Video Series

Lexaria Updates Progress on Human Study #7

biotech investing

Lexaria Updates Progress on Human Study #7

Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications

biotech investing

Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications

Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

biotech investing

Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

biotech investing

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

biotech investing

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

biotech investing

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

biotech investing

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

Lexaria to Begin New Human Clinical Study in GLP-1

Lexaria to Begin New Human Clinical Study in GLP-1

Lexaria's Robust Patent Portfolio Continues to Grow

Lexaria's Robust Patent Portfolio Continues to Grow

Lexaria's Oral GLP-1 Drug Strategy Validated by Industry

Lexaria's Oral GLP-1 Drug Strategy Validated by Industry

Latest News

JV Technical & Financial Evaluation

Trading Halt

Emperor Metals Returns 15.0 Meters of 61.5 g/t Gold Including 2.4 Meters of 369.6 g/t Gold

Copper Quest Expands its Kitimat Copper Gold Project

Syntholene Energy Corp. Appoints Former Suncor, Shell Operations Executive Marc Mageau to Advisory Board

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

GoldInxs Mining

GoldInxs Mining (None)

Finlay Minerals

Finlay Minerals (FYL:CC)

FYL:CC

Coelacanth Energy

Coelacanth Energy (CEI:CC)

CEI:CC

Sankamap Metals

Sankamap Metals (SCU:CC)

SCU:CC

Red Mountain Mining

Red Mountain Mining (RMX:AU)

RMX:AU

Jameson Resources

Jameson Resources (JAL:AU)

JAL:AU

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES